ArticleFrontiers in immunology2025

Preexisting ulcerative colitis increases the risk of immune-related colitis and predicts divergent survival outcomes in gastrointestinal cancer patients treated with immune checkpoint inhibitors.

Shuo Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.